Dyne Therapeutics, Inc. 4

Edward Hurwitz was awarded stock options for 35,152 shares of Dyne Therapeutics, Inc. common stock at a $17.04 exercise price as a compensatory grant.

On June 5, 2026, Edward Hurwitz received a grant of stock options for 35,152 shares of Dyne Therapeutics, Inc. common stock at an exercise price of $17.04 per share, reported as an acquisition transaction at zero cost. These options are scheduled to vest in full on the earlier of June 5, 2027, or the date of the issuer's 2027 Annual Meeting of Stockholders, contingent on continued service. Following this grant, Hurwitz holds derivative securities representing 35,152 underlying shares, indicating this is a compensatory award rather than an open-market purchase or sale, and no immediate cash outlay or sale proceeds are involved.

Filing Facts

CIK

1818794

Ticker

DYN

Form

4

Source Type

sec

Accession

0001193125-26-264031

Alert Tier

5